For Genetics EQA please see the South West Genomic Laboratory Hub website SWGLH Quality | North Bristol NHS Trust
All departments within Severn Pathology participate within External Quality Assurance Schemes where possible. Where external quality assurance schemes are not available, the laboratories will explore alternative mechanisms such as Internal Quality Assessment or Inter-Laboratory Exchange with other diagnostic laboratories.
N.B. All scores are confidential to the participating organisation. However, we will inform our users should we receive a letter of poor performance in any particular scheme.
Antimicrobial Reference Laboratory
| Scheme Provider | Scheme |
|---|---|
UKNEQAS Antibiotics | Amikacin, Teicoplanin, Tobramycin |
UKNEQAS Antifungals | Itraconazole, Posaconazole, Voriconazole, Flucytosine, Isavuconazole |
INSTAND Group 198 (Antifungals/Chloramphenicol) | Posaconazole, Voriconazole, Fluconazole, Flucytosine, Chloramphenicol |
Instand Group 890 (Antibacterials 02) | Meropenem, Linezoid |
SKML (Snti-Tb Drugs) | Ethambutol, Isoniazid, Acetyl-Isoniazid (Isoniazid metabolite), Rifampicin, Rifabutin, Levofloxacin, Moxifloxacin, Linezolid, Bedaquiline |
SKML (Antibiotic Drugs II | Piperacillin, Ciprofloxacin, Flucloxacillin, Sulphamethoxazole (Co-Trimoxazole), Trimethoprim (Co-Trimoxazole) |
| SKML (Antiviral Drugs) | Aciclovir, Ganciclovir |
Bacteriology
Scheme Provider | Scheme |
|---|---|
UK NEQAS | AAFB microscopy |
Aurevia | Blood cultures |
BMS EQA | Gram stain - vaginitis |
QCMD | MALDI |
Mycology Reference Laboratory
| Scheme Provider | Scheme |
|---|---|
UKNEQAS Microbiology | Fungal Biomarkers, Cryptococcal antigen, Beta glucan (trial) |
UKNEQAS Immunology | Fungal & related antigens |
Aurevia | Fungal culture & sens |
QCMD | Candida DNA, Aspergillus DNA, PCP DNA |
Virology
Scheme Provider | Scheme |
|---|---|
UK NEQAS | Anti-HBs detection |
CSCQ | Lyme serology |
Aurevia | Antistreptolysin serology |
QCMD | Adenovirus DNA |
Instand eV | Chlamydia serology (C. trachomatis serology) |
Clinical Biochemistry
Scheme Provider | Scheme |
|---|---|
UKNEQAS - general Chemistry assays | Sodium, potassium, chloride, bicarbonate, urea, urate, glucose. Lactate, calcium, adjusted calcium, phosphate, bilirubin, iron, transferrin, total protein, albumin, magnesium, AST, ALT, LD, CK, ALP, amylase, GGT, lipase, AFP (Tumour) Albumin, AMH, B12, Ca-125 .Ca15-3, Ca19-9, CEA, Bililrubin, Cholesterol Creatinine, CRP, Ferritin, Folate, Glucose, Haem pigments, HCG, Icterus, Lactate, Lipaemia, Lipase, Macroprolactin, Parathyroid hormone, PSA, SHBG, Total Bilirubin, Total Protein, Triglycerides, Urea, Vitamin D |
| UKNEQAS | Erythropoetin (EPO) General Immune Serology (TPO) Intrinsic Factor Antibodies (IFAB) Lipids Paracetamol, salicylate, ethanol & TDM Peptide hormones FSH, LH, Prolactin, macroprolactin, AMH Thyroid |
| UKNEQAS | Fluids (total protein, albumin, glucose, amylase, creatinine, urea, lactate, total cholesterol, triglyceride) |
UKNEQAS | Urine Chemistry (electrolytes, osmolality, protein, calcium, albumin) |
UKNEQAS | CSF Spectroscopy scheme |
German Scheme RfB | Blood spot 17OH progesterone |
| ERNDIM | Acylcarnitines in Serum (carnitine) ACDB scheme (Acylcarnitine’s in dried blood spots, includes interpretation) |
ERNDIM | DPT Scheme (Diagnosis Proficiency Testing) |
ERNDIM | Special assays in urine (GTL) |
ERNDIM | QLOU scheme (Qualitative Organic Acids in urine) |
ERNDIM | Quantitative amino acids |
ERNDIM | Quantitative methyl malonic acid (ORGS) (urine) |
ERNDIM | Quantitative special serum assays (hydroxybutyrate, phytanate, VLCFA, pristanate, 7-dehydrocholesterol, free carnitine, NEFA ) |
ERNDIM | CN, PHE and TYR in dried blood spots |
Centre for Disease Control (USA) | CDC DBS galactose-1-phosphate uridyltransferase (GALT) |
UKNEQAS | Newborn screening includes following blood spot markers (TSH, IRT on the GSP) |
| UKNEQAS | Newborn screening for markers Phe, Tyr, C8 , C10, C8/10 |
UKNEQAS | Sickle Cell |
| LGC International Proficiency Scheme | Antipsychotics/SSRI/TCA Carboxyhaemoglobin Case studies for toxicology Ethanol (blood, urine, serum) Paracetamol Tacrolimus, Cyclosporin and Sirolimus Toxicology Serum Toxic Alcohols |
UKNEQAS | Cholinesterase inhibitor and activity |
| RIQAS | Urine drugs of abuse |
| Equalis (Swedish) | Iohexol |
Instand Ev | Gentomycin, Vancomicin |
Immunology
Scheme Provider | Scheme |
|---|---|
UK NEQAS | Paraneoplastic Antibodies |
UK NEQAS | B2Microglobulin |
UK NEQAS | C1 Esterase Inhibitor and Functional Complement Assays |
UK NEQAS | Monoclonal Protein Identification |
UK NEQAS | General Autoimmune Serology |
UK NEQAS | Antibodies to Nuclear and Related Antigens |
UK NEQAS | Alkaline Phosphatase Isoenzymes |
UK NEQAS | Bullous Dermatosis |
UK NEQAS | IgG Subclasses |
UK NEQAS | IgE |
UK NEQAS | Allergen Specific IgE |
UK NEQAS | Neutrophil Cytoplasmic and Glomerular Basement Membrane Antibodies |
UK NEQAS | Coeliac Disease Antibodies |
UK NEQAS | Diabetic Markers |
UK NEQAS | Specific Proteins |
UK NEQAS | CSF IgG Oligoclonal Bands |
UK NEQAS | Faecal Markers |
UK NEQAS | CSF for Beta 2 Transferrin |
UK NEQAS | Alpha 1 Antitrypsin Phenotype Identification |
UK NEQAS | ACHR Antibodies |
UK NEQAS | Phospholipid Antibodies |
UK NEQAS | Tryptase |
UK NEQAS | Fungal and Related Antigens |
UK NEQAS | Immune Monitoring |
UK NEQAS | Leukaemia Immunophenotyping |
UK NEQAS | Leukaemia Interpretation Scheme |
UK NEQAS | Measurable Residual Disease for Acute lymphoblastic Leukaemia |
UK NEQAS | Interferon Gamma Release Assay - TB |
UK NEQAS | Paroxysmal Nocturnal Haemoglobinuria |
UK NEQAS | Allergen Component Testing |
UK NEQAS | ABO Titration |
UK NEQAS | Scheme 1B HLA-B27 Testing |
UK NEQAS | Scheme 2B Crossmatching by Flow Cytometry - B cell |
UK NEQAS | Scheme 2B Crossmatching by Flow Cytometry - T cell |
UK NEQAS | Scheme 3 HLA Antibody Specificity Analysis |
UK NEQAS | Scheme 4A1 HLA DNA Typing 1st Field Only |
UK NEQAS | Scheme 6 HLA Antibody Detection |
UK NEQAS | Scheme 7 HLA-B57:01 Typing |
UK NEQAS | Scheme 8 HLA Genotyping for Coeliac and other HLA associated diseases |
UK NEQAS | Cryoproteins |
UK NEQAS | Myositis Antibodies |
UK NEQAS | Faecal Pancreatic Elastase |
UK NEQAS | Measurable Residual Disease in Chronic Lymphoblastic Leukaemia (pilot) |
UK NEQAS | Measurable Residual Disease in Acute Myeloid Leukaemia (pilot) |
UK NEQAS | Educational Crossmatch Scheme |
WEQAS | Quantitative Faecal Hb |
UK NEQAS | Phospholipase A2 Receptor Antibody |
UK NEQAS | CSF Immunophenotyping (pilot) |
Cellular Pathology
Scheme Provider | Scheme |
|---|---|
UK NEQAS | UK NEQAS for Cellular Pathology Tecnique - Tissue Diagnostics |
UK NEQAS | UK NEQAS for Cellular Pathology Tecnique - Specialist Techniques |
UK NEQAS | UK NEQAS for Cellular Pathology Technique - Mohs procedure |
UK NEQAS | UK NEQAS for Cellular Pathology Technique - Bone Marrow Trephine |
UK NEQAS | UK NEQAS for Cellular Pathology Technique - Renal biopsy |
UK NEQAS | UK NEQAS for Cellular Pathology Technique - Mega Block and slide H&E |
UK NEQAS | UK NEQAS for Cellular Pathology Technique - Frozen section H&E |
UK NEQAS | UK NEQAS for Cellular Pathology Technique - Direct Immunofluorescence |
UK NEQAS | UK NEQAS for Cellular Pathology Technique - Digital Pathology |
UK NEQAS | UK NEQAS for Immunocytochemistry and In-Situ Hybridisation - General Pathology |
UK NEQAS | UK NEQAS for Immunocytochemistry and In-Situ Hybridisation - Breast Pathology (Hormonal Receptors – ER/PR) |
UK NEQAS | UK NEQAS for Immunocytochemistry and In-Situ Hybridisation - Breast HER2 IHC |
UK NEQAS | UK NEQAS for Immunocytochemistry and In-Situ Hybridisation - Breast HER2 ISH |
UK NEQAS | UK NEQAS for Immunocytochemistry and In-Situ Hybridisation - Lymphoid Pathology |
UK NEQAS | UK NEQAS for Immunocytochemistry and In-Situ Hybridisation - Alimentary Tract Pathology (Lynch Syndrome/HNPC) |
UK NEQAS | UK NEQAS for Immunocytochemistry and In-Situ Hybridisation - Gastric HER2 IHC |
UK NEQAS | UK NEQAS for Immunocytochemistry and In-Situ Hybridisation - Non-Small Cell Lung carcinoma (NSCLC) ALK IHC |
UK NEQAS | UK NEQAS for Immunocytochemistry and In-Situ Hybridisation - Non-Small Cell Lung carcinoma (NSCLC) PD-L1 IHC |
UK NEQAS | UK NEQAS for Immunocytochemistry and In-Situ Hybridisation - Mis-Match Repair Proteins |
UK NEQAS | UK NEQAS for Immunocytochemistry and In-Situ Hybridisation - Head and Neck HPV |
UK NEQAS | UK NEQAS for Immunocytochemistry and In-Situ Hybridisation - Head and Neck P16 |
UK NEQAS | UK NEQAS for Immunocytochemistry and In-Situ Hybridisation - Cytopathology |
Inter-laboratory comparison | Immunohistochemistry and In-Situ Hybridisation - various |
Inter-laboratory comparison | Immunohistochemistry various |
Inter-laboratory comparison | In-Situ Hybridisation - various |
LABQUALITY | Synovial Fluid Crystals |
UK NEQAS | Diagnostic Cytology Cell Block |
UK NEQAS | Diagnostic Cytology |
UK NEQAS | Interpretive (Digital) |
UK NEQAS | HPV |
QCMD | HPV |
Screening Quality Assurance Service | Gynaecological |
Screening Quality Assurance Service | Technical |
Haematology
Scheme Provider | Scheme |
|---|---|
UK NEQAS | Full Blood Count |
UK NEQAS | G6PD |
UK NEQAS | Auto WBC Differential |
UK NEQAS | Retic Count |
UK NEQAS | Haemoglobinopathy |
UK NEQAS | Sickle Screen |
UK NEQAS | Cytochemistry, FE Stain |
UK NEQAS | Blood Film Morphology/Parasitology |
UK NEQAS | Manual WBC Differential |
UK NEQAS | Rapid Malaria Antigen Test |
UK NEQAS | nRBCc |
UK NEQAS | Plasma Viscosity |
UK NEQAS | Ferritin |
UK NEQAS | Intrinsic Factor Antibodies |
UK NEQAS | B12/Folate |
UK NEQAS | HbA1c |
UK NEQAS | INR/PT |
UK NEQAS | APTT |
UK NEQAS | Thrombin Time |
UK NEQAS | Heparin Dosage Assessment |
UK NEQAS | Heparin Assay |
UK NEQAS | Fibrinogen |
UK NEQAS | D-Dimer |
UK NEQAS | Coagulation Factor Assays: VIII, IX II,V,VII,XI,XII,FXIII |
UK NEQAS | VWF RiCof VWF antigen |
UK NEQAS | Antithrombin Activity |
UK NEQAS | Protein C Activity |
UK NEQAS | Free Protein S Antigen |
UK NEQAS | Activated Protein C resistance |
UK NEQAS | Lupus Antigoagulant |
UK NEQAS | Blood Transfusion |
UK NEQAS | BTLP (Blood Transfusion) |
UK NEQAS | FMH (Blood Transfusion) Acid Elution |
ECAT (Dutch EQA Scheme) | Anti-Xa tests |